Notable Labs, Ltd. NTBLQ
0.00
0.00
NaN
as of 24 Sep
- Market cap
- $2.4M
- P/E
- 0.0×
Follow NTBLQ
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '23 | Dec '23 | Mar '24 | Jun '24 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | 0.64 | 0.11 |
P/S ratio |
— | — | 0.00 | 0.00 | |
P/FCF ratio |
— | — | 0.00 | 0.00 | |
P/Operating CF |
— | — | (4.28) | (1.50) | |
P/B ratio |
— | — | 1.32 | 0.78 | |
Price to Tangible BV |
— | — | 1.32 | 0.78 | |
EV/Sales |
— | — | (70.31) | (10.31) | |
EV/EBITDA |
— | — | 0.00 | 0.00 | |
EV/Operating CF |
— | — | (0.51) | (0.11) | |
EV/FCF |
— | — | (0.51) | (0.11) | |
Quick Ratio |
7.98 | 4.32 | 3.25 | 1.63 | |
Current Ratio |
8.05 | 5.65 | 4.66 | 2.77 | |
Net Debt/EBITDA |
20.69 | 2.12 | 2.10 | 0.73 | |
Debt/Assets |
0.00% | 1.35% | 1.56% | 2.04% | |
Debt/Equity |
0.00 | 0.02 | 0.02 | 0.03 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | (0.01) | |
Operating CF/Net income |
1.69 | 12.40 | 0.95 | 0.71 | |
Capex/Depreciation |
0.00 | (29.26) | (0.10) | (0.12) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 155,000.00% | 117,700.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 228,900.00% | 151,400.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 13,200.00% | 45,950.00% | |
Graham Net Nets |
— | — | 0.50 | 0.57 | |
Graham Number |
— | — | 8.71 | 9.80 | |
Earnings Yield |
— | — | 155.68% | 952.68% | |
Free Cash Flow Yield |
— | — | (94.62%) | (272.50%) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.81) | (1.84) | (0.39) | (0.39) | |
Capex per Share |
3.34 | (2.28) | 0.00 | 0.00 | |
Free Cash Flow per Share |
2.54 | (4.12) | (0.40) | (0.39) | |
Cash per Share |
9.28 | 3.58 | 0.91 | 0.43 | |
Shareholders Equity per Share |
8.19 | 4.58 | 1.28 | 0.76 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
8.19 | 4.58 | 1.28 | 0.76 | |
Free Cash Flow |
5.68 | (13.59) | (3.57) | (3.72) | |
Working Capital |
18.34 | 12.73 | 9.20 | 4.47 | |
Capital Expenditures |
7.48 | (7.52) | (0.01) | (0.01) | |
Net Current Asset Value |
18.34 | 11.04 | 7.66 | 3.17 | |
EV/EBIT |
— | — | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 6.00 | 4.00 | |
Net Profit Margin |
0.00% | 0.00% | (376,600.00%) | (260,950.00%) | |
Price to Operating Income |
— | — | 0.00 | 0.00 | |
| Other line items | |||||
Average Payables |
4.88 | 1.31 | 4.65 | 1.71 | |
Average Assets |
28.23 | 12.53 | 21.86 | 17.83 | |
Average Common Equity |
21.82 | (10.93) | 15.72 | 13.21 |
Columns are period end dates